No abstract available
MeSH terms
-
Adolescent
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucagon-Like Peptides / adverse effects
-
Humans
-
Immunoglobulin Fc Fragments / adverse effects
-
Recombinant Fusion Proteins / adverse effects
Substances
-
dulaglutide
-
Glucagon-Like Peptides
-
Immunoglobulin Fc Fragments
-
Recombinant Fusion Proteins